Global Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030

Global Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030

Global transfection reagents and equipment market is projected to register a substantial CAGR of 9.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030. Market Segmentation: Global Transfection Reagents and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagents and Equipment, Stable Transfection Reagents, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (By Type and By Industry), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Belgium, Ireland, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E, Israel, Egypt, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030

Some of the drivers that boost transfection reagents and equipment market’s growth are as follows:
• Rise in the prevalence of chronic diseases
• Development of synthetic biology products

Market Players: Some of the major players operating in the global transfection reagents and equipment market are:
• Mirus Bio LLC.
• Promega Corporation
• Polyplus Transfection
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Lonza
• MaxCyte, Inc.
• Altogen Biosystems
• SBS Genetech
• FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation)
• Avanti Polar Lipids (A Subsidiary of Croda International Plc)
• PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
• Cytiva
• Geno Technology Inc., USA
• R&D Systems, Inc.
• Takara Bio Inc.
• Thermofisher Scientific Inc.
• Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd),
• OriGene Technologies, Inc.
• Applied Biological Materials Inc. (abm)
• Beckman Coulter, Inc. (A Subsidiary of Danaher)
• SignaGen Laboratories
• Genlantis Inc.
• Ginkgo Bioworks

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.